Skip to main content
. 2016 Dec 20;13(1):71–87. doi: 10.1007/s13181-016-0595-z

Table 5.

Proposed treatments for CHS

Proposed treatment Supportive evidence Author Study design GRADE rating
Cessation of cannabis Cessation of cannabis led to resolution of symptoms in 30 of 31 patients Wallace [10] Case series Very low
Among 10 CHS patients with follow-up, 30% did not abstain and continued to have symptoms and 60% stopped using and had complete resolution of symptoms. One patient experienced no symptomatic improvement with self-reported abstinence. Simonetto [16] Case series Very low
Among 10 patients, 7 of 10 abstained and had resolution of symptoms. Three patients did not and illness continued. Three patients rechallenged themselves after a period of abstinence, and all suffered a return to illness Allen [6] Case series Very low
Application of capsaicin cream to the abdomen Five CHS patients experienced near complete resolution of symptoms after application of topical capsaicin cream to the abdomen LaPoint [168] Case series Very low
Case report of dramatic relief of symptoms in CHS patient with topical application of capsaicin Biary [169] Case report Very low
Dopamine antagonists Δ9-THC increases dopamine synthesis, turnover, and efflux and dopamine cell firing. Δ9-THC withdrawal, induced by abrupt discontinuation of chronic Δ9-THC treatment or administration of rimonabant, results in decreased dopamine efflux and neurotransmission Schulze [103] Experimental model Very low
CHS patient received 5 mg haloperidol and experienced complete resolution of symptoms within 1 h Hickey [40] Case report Very low
Avoidance of opiate-based medications Opioid analgesic use is associated with bowel dysfunction, and GI side effects have been reported in up to 47% of opioid-treated patients Argoff [188] Review Very low
Opiates should be used with caution as they have the potential to cause emesis Galli [170] Case report Very low
HHS Vulnerability Disclosure